BENJAMIN PROHASKA: Open Payments
NPI 1174652143 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,464 in 165 payments from 18 companies in 2025. Trend: 2023 $12,145 · 2024 $4,005 · 2025 $4,464
Food & beverage: $2,874Consulting: $1,590
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $1,780 |
| Medtronic, Inc. | 32 | $451 |
| Mannkind Corporation | 21 | $392 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $264 |
| Xeris Pharmaceuticals, Inc. | 18 | $250 |
| Corcept Therapeutics | 15 | $240 |
| Amgen Inc. | 11 | $233 |
| RECORDATI_RARE_DISEASES_INC. | 12 | $204 |
| Lilly USA, LLC | 10 | $188 |
| SANOFI-AVENTIS U.S. LLC | 5 | $106 |
Products named: Rybelsus, AFREZZA, JARDIANCE, MINIMED 780G, Korlym, SIMPLERA SENSOR, TEPEZZA, ISTURISA.
Industry payments across NV — which companies pay providers there.
